Dr. Peter Grogg, Ph.D., is a Swiss businessman, the self-made billionaire Founder and former Executive of Bachem Holding AG (SWX: BANB), a global leader in peptides and complex organic molecules (essential components for pharmaceutical and biotech R&D). His career is rooted in elite organic chemistry, science, and entrepreneurial audacity.

Grogg holds a Ph.D. in Chemistry from the University of Zurich. His philosophical approach centers on technological excellence, scale manufacturing, and long-term commitment to biomedical research (providing essential building blocks for next-generation drugs). He founded Bachem in 1971, recognizing the immense, untapped global demand for high-quality, custom-synthesized peptides.

• Bachem Holding AG (Founder & Former Executive): The core publicly traded asset, a global leader in peptide chemistry, APIs, and complex organic molecules (a key supplier to the pharmaceutical industry).
• Biotech Pioneer: His success is built on scale manufacturing and R&D in essential peptide-based therapeutics and research tools.
• Academic Background: He holds a Ph.D. in Chemistry from the University of Zurich.
• Investment Strategy: His philosophy is rooted in long-term investment in scientific R&D and leveraging the massive global growth of the biotechnology sector.

Dr. Peter Grogg's strategic genius was his commitment to technological specialization. He founded Bachem in 1971, successfully building it into the world's dominant supplier of peptides (essential components for many modern drugs). His structural contribution is immense: pioneering the industrial scale and quality of the specialized peptide manufacturing sector globally.

The company successfully executed its IPO on the SIX Swiss Exchange (SWX). He stepped down as Executive Chairman in 2012 (remaining a major shareholder). His wealth is secured by the colossal, long-term, stable profitability of the global biotechnology, pharmaceutical, and specialty chemical sectors.

Dr. Peter Grogg's social impact is structural, stemming from Bachem's role in providing essential chemical building blocks that accelerate drug discovery and development for global pharmaceutical companies. His companies contribute significantly to biomedical innovation. His personal philanthropy supports various community and educational initiatives (including funding chemistry research).

His structural contribution is tied to the successful industrialization and scale of the specialized biotechnology components sector.

Dr. Peter Grogg maintains the professional, composed style of a science-executive. His attire is consistently formal and high-quality, favoring tailored suits. His aesthetic reflects serious authority and stability, typical of a pioneer in the specialized biotechnology sector.

Residing in Basel, Switzerland, his luxury is the immense security and financial reward derived from his multi-billion dollar fortune. His life is dedicated to biotechnology innovation, scientific integrity, and investment strategy.